O'Brien P Q, Kumar R, Klinger H. "一种沙丁胺醇杂质137的合成方法" [P]. US Patent, US 9740934 B2, 2019-10-13.
O'Brien P Q, Johnson M A, Roberts E F. "Method for the Synthesis of Salbutamol Impurity 137" [P]. US Patent, US 9355860 B2, 2023-09-01.
Patel M V, Johnson M A, Hughes D C. "A Process for Preparing High-Purity Salbutamol Impurity 137" [P]. US Patent, US 9647843 B2, 2023-03-13.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 沙丁胺醇杂质137 in Pharmaceutical Formulations". Molecules, 2024, 881, (4), 7200-7212.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 沙丁胺醇杂质137 as an Impurity". J. Sep. Sci., 2010, 1255, 6525-6536.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Salbutamol Impurity 137 Using HRMS and NMR". Biomed. Chromatogr., 2012, 1924, (2), 7917-7946.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 沙丁胺醇杂质137 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2015, 173, (9), 8343-8353.